Literature DB >> 28202701

Chronobiology differs between men and women with cluster headache, clinical phenotype does not.

Nunu Lund1, Mads Barloese2, Anja Petersen2, Bryan Haddock2, Rigmor Jensen2.   

Abstract

OBJECTIVE: To describe differences between the sexes in the phenotype of cluster headache (CH) in a large, well-characterized clinical CH population.
METHODS: Patients from the Danish CH survey aged 18-65 years, diagnosed with CH according to International Classification of Headache Disorders, second edition, completed questionnaires and structured interviews.
RESULTS: A total of 351 patients with CH participated, with a male:female ratio of 2:1. The diurnal variation of attacks showed moments of peak prominence in men's attack cycle to be advanced by 1 hour compared to women's, despite no difference in self-reported bedtime or chronotype (p = 0.31). The onset of CH decreased with increasing age for both sexes. Diagnostic delay was numerically longer for men vs women (6.56 vs 5.50 years, p = 0.21); however, more women had previously been misdiagnosed (61.1% vs 45.5%, p < 0.01) and received the correct diagnosis at a tertiary headache center (38.8% vs 20.9%, p < 0.001). Only minor sex differences in clinical characteristics were found but chronic CH was more prevalent in women compared to men (44.0% vs 31.9%, p < 0.05).
CONCLUSIONS: Despite a similar clinical phenotype, diurnal attack cycle is advanced by 1 hour in men with CH compared to women. Rhythmicity is a defining characteristic of CH and these findings suggest differences in the hypothalamus' influence on attack occurrence between the sexes. In addition, women were more often misdiagnosed and diagnosis in the primary or secondary sector more often failed. Furthermore, women had chronic CH more frequently than men. A long diagnostic delay and frequent misdiagnosis emphasize the need for increased awareness of CH in both sexes.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28202701     DOI: 10.1212/WNL.0000000000003715

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  The pathophysiology of the trigeminal autonomic cephalalgias, with clinical implications.

Authors:  Mads C J Barloese
Journal:  Clin Auton Res       Date:  2017-09-23       Impact factor: 4.435

Review 2.  Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Authors:  Emmanuelle A D Schindler
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study.

Authors:  Alina Buture; Fayyaz Ahmed; Yachna Mehta; Koen Paemeleire; Peter J Goadsby; Lisa Dikomitis
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

4.  Development and Evaluation of a Screening Tool to Aid the Diagnosis of a Cluster Headache.

Authors:  Alina Buture; Jason W Boland; Lisa Dikomitis; Chao Huang; Fayyaz Ahmed
Journal:  Brain Sci       Date:  2020-02-01

Review 5.  Pharmacotherapy for Cluster Headache.

Authors:  Roemer B Brandt; Patty G G Doesborg; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 6.  Exploring the Connection Between Sleep and Cluster Headache: A Narrative Review.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Jo Ann LeQuang; Charles Wollmuth; Robert Taylor; Frank Breve
Journal:  Pain Ther       Date:  2020-05-07

7.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020.

Authors:  Henrik W Schytz; Faisal M Amin; Rigmor H Jensen; Louise Carlsen; Stine Maarbjerg; Nunu Lund; Karen Aegidius; Lise L Thomsen; Flemming W Bach; Dagmar Beier; Hanne Johansen; Jakob M Hansen; Helge Kasch; Signe B Munksgaard; Lars Poulsen; Per Schmidt Sørensen; Peter T Schmidt-Hansen; Vlasta V Cvetkovic; Messoud Ashina; Lars Bendtsen
Journal:  J Headache Pain       Date:  2021-04-08       Impact factor: 7.277

Review 8.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

9.  Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts.

Authors:  Ruth Ruscheweyh; Gregor Broessner; Gudrun Goßrau; Katja Heinze-Kuhn; Tim P Jürgens; Katharina Kaltseis; Katharina Kamm; Andreas Peikert; Bianca Raffaelli; Florian Rimmele; Stefan Evers
Journal:  Cephalalgia       Date:  2020-08-17       Impact factor: 6.292

10.  Cluster headache in Asian populations: Similarities, disparities, and a narrative review of the mechanisms of the chronic subtype.

Authors:  Kuan-Po Peng; Tsubasa Takizawa; Mi Ji Lee
Journal:  Cephalalgia       Date:  2020-05-12       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.